A carregar...
Evaluating measurable residual disease in acute myeloid leukemia
Mounting evidence indicates that the presence of measurable (“minimal”) residual disease (MRD), defined as posttherapy persistence of leukemic cells at levels below morphologic detection, is a strong, independent prognostic marker of increased risk of relapse and shorter survival in patients with ac...
Na minha lista:
| Publicado no: | Blood Adv |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5998930/ https://ncbi.nlm.nih.gov/pubmed/29895626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018016378 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|